[Pricing] compounded tirz pricing in my state, six months of receipts
The title is the argument: compounded tirz pricing in my state, six months of receipts. Here is the rest of it. A 503A pharmacy compounds for an identified patient against a prescription. A 503B outsourcing facility registers with the regulator, may produce without patient-specific prescriptions, and is subject to…
Kept the label from every vial. When the shortage status changed, having the paper trail made the conversation much shorter.
Potency and sterility testing on the finished preparation are separate from any certificate covering the starting material. Ask which you are being shown.
Concentration on the compounded vial was different from what I had been using and I nearly did the arithmetic on autopilot.
Asked for the beyond-use date basis and got a real answer with a stability reference attached. Not universal, apparently.
Same view. If the intake asked you nothing, the intake was a formality and you should factor that in.
a 503B has to register and report, so there is a paper trail to ask for
Yes. The shortage list is the legal hinge for the whole arrangement and its status is public.
The shortage list is the legal hinge: the permissions that allow certain compounding to happen at scale are tied to a drug’s shortage status, which changes.
Kept the label from every vial.
Agreed — and the follow-up question is what the beyond-use date is based on.